CNR1 and prostate cancer: Collectively, these findings indicate that although CBRs in human prostate cancer cells lines PC-3 and DU-145 exhibit atypical binding properties, these cells nevertheless express mRNA for canonical CB1 and CB2 receptors, with CB2R mRNA being dramatically upregulated in both cancer cell lines relative to normal prostate tissue.